Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880592 · ClinicalTrials.gov registry record · NA
Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers
A NA study, sponsored by Organogenesis.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02880592 is a NA study that has completed, run by Organogenesis. The registered enrollment target is 89 participants.
The verdict
NCT02880592, a NA study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
This is a multi-center, randomized controlled trial designed to evaluate the use of fresh hypothermically stored human amniotic membrane (Affinity; fHSAM) to determine if addition of fHSAM to standard of care (SOC) results in faster healing of Wagner grade 1 and 2 DFUs compared to SOC alone.
Interventions
- OTHER Standard of care
- OTHER Affinity Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02880592
The ClinicalTrials.gov registry entry for NCT02880592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT02880592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02880592 about?
NCT02880592 is a clinical study titled "Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers". This is a multi-center, randomized controlled trial designed to evaluate the use of fresh hypothermically stored human amniotic membrane (Affinity; fHSAM) to determine if addition of fHSAM to standard of care (SOC) results in faster healing of Wagner grade 1 and 2 DFUs compared to SOC alone.
What is the current status of trial NCT02880592?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2016-08. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT02880592?
The interventions under investigation include: Standard of care (OTHER), Affinity Allograft (OTHER).
Who is sponsoring clinical trial NCT02880592?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.